Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus

T. F. Yeh, A. Wilks, J. Singh, M. Betkerur, L. Lilien, R. S. Pildes

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

To determine if furosemide would prevent the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus, 19 premature infants were randomized into two groups: nine received indomethacin alone, and ten received indomethacin followed immediately by furosemide. There was no significant difference between the groups in birth weight, gestational age, postnatal age, and in cardiopulmonary or renal status at the time of study. Infants who received indomethacin and furosemide had significantly higher urine output (P<0.05), higher FENa and FECl (P<0.01), and higher glomerular filtration rate (P<0.05) than those of infants who received indomethacin alone. Seven infants in each group responded to indomethacin therapy with disappearance of PDA murmur and improvement of cardiovascular status. The results of this study suggest that furosemide may prevent the renal side effects of indomethacin therapy and yet not affect the efficacy of indomethacin in the closure of a PDA.

Original languageEnglish
Pages (from-to)433-437
Number of pages5
JournalThe Journal of Pediatrics
Volume101
Issue number3
DOIs
Publication statusPublished - Jan 1 1982
Externally publishedYes

Fingerprint

Patent Ductus Arteriosus
Furosemide
Premature Infants
Indomethacin
Kidney
Therapeutics
Time and Motion Studies
Glomerular Filtration Rate
Birth Weight
Gestational Age
Urine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. / Yeh, T. F.; Wilks, A.; Singh, J.; Betkerur, M.; Lilien, L.; Pildes, R. S.

In: The Journal of Pediatrics, Vol. 101, No. 3, 01.01.1982, p. 433-437.

Research output: Contribution to journalArticle

Yeh, T. F. ; Wilks, A. ; Singh, J. ; Betkerur, M. ; Lilien, L. ; Pildes, R. S. / Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. In: The Journal of Pediatrics. 1982 ; Vol. 101, No. 3. pp. 433-437.
@article{c2ab362e68ab4814bdde3246c453f6a9,
title = "Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus",
abstract = "To determine if furosemide would prevent the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus, 19 premature infants were randomized into two groups: nine received indomethacin alone, and ten received indomethacin followed immediately by furosemide. There was no significant difference between the groups in birth weight, gestational age, postnatal age, and in cardiopulmonary or renal status at the time of study. Infants who received indomethacin and furosemide had significantly higher urine output (P<0.05), higher FENa and FECl (P<0.01), and higher glomerular filtration rate (P<0.05) than those of infants who received indomethacin alone. Seven infants in each group responded to indomethacin therapy with disappearance of PDA murmur and improvement of cardiovascular status. The results of this study suggest that furosemide may prevent the renal side effects of indomethacin therapy and yet not affect the efficacy of indomethacin in the closure of a PDA.",
author = "Yeh, {T. F.} and A. Wilks and J. Singh and M. Betkerur and L. Lilien and Pildes, {R. S.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/S0022-3476(82)80079-6",
language = "English",
volume = "101",
pages = "433--437",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus

AU - Yeh, T. F.

AU - Wilks, A.

AU - Singh, J.

AU - Betkerur, M.

AU - Lilien, L.

AU - Pildes, R. S.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - To determine if furosemide would prevent the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus, 19 premature infants were randomized into two groups: nine received indomethacin alone, and ten received indomethacin followed immediately by furosemide. There was no significant difference between the groups in birth weight, gestational age, postnatal age, and in cardiopulmonary or renal status at the time of study. Infants who received indomethacin and furosemide had significantly higher urine output (P<0.05), higher FENa and FECl (P<0.01), and higher glomerular filtration rate (P<0.05) than those of infants who received indomethacin alone. Seven infants in each group responded to indomethacin therapy with disappearance of PDA murmur and improvement of cardiovascular status. The results of this study suggest that furosemide may prevent the renal side effects of indomethacin therapy and yet not affect the efficacy of indomethacin in the closure of a PDA.

AB - To determine if furosemide would prevent the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus, 19 premature infants were randomized into two groups: nine received indomethacin alone, and ten received indomethacin followed immediately by furosemide. There was no significant difference between the groups in birth weight, gestational age, postnatal age, and in cardiopulmonary or renal status at the time of study. Infants who received indomethacin and furosemide had significantly higher urine output (P<0.05), higher FENa and FECl (P<0.01), and higher glomerular filtration rate (P<0.05) than those of infants who received indomethacin alone. Seven infants in each group responded to indomethacin therapy with disappearance of PDA murmur and improvement of cardiovascular status. The results of this study suggest that furosemide may prevent the renal side effects of indomethacin therapy and yet not affect the efficacy of indomethacin in the closure of a PDA.

UR - http://www.scopus.com/inward/record.url?scp=0019984049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019984049&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(82)80079-6

DO - 10.1016/S0022-3476(82)80079-6

M3 - Article

C2 - 7108667

AN - SCOPUS:0019984049

VL - 101

SP - 433

EP - 437

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -